Bausch Health EBITDA vs. Price To Book
| BHC Stock | CAD 10.71 0.07 0.66% |
EBITDA | First Reported 2010-12-31 | Previous Quarter 2.2 B | Current Value 1.3 B | Quarterly Volatility 1.4 B |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.81 | 0.7078 |
|
|
For Bausch Health profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Bausch Health to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Bausch Health Companies utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Bausch Health's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Bausch Health Companies over time as well as its relative position and ranking within its peers.
Bausch |
Bausch Health Companies Price To Book vs. EBITDA Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Bausch Health's current stock value. Our valuation model uses many indicators to compare Bausch Health value to that of its competitors to determine the firm's financial worth. Bausch Health Companies is number one stock in ebitda category among its peers. It also is number one stock in price to book category among its peers . The ratio of EBITDA to Price To Book for Bausch Health Companies is about 117,487,622 . At this time, Bausch Health's EBITDA is very stable compared to the past year. Comparative valuation analysis is a catch-all model that can be used if you cannot value Bausch Health by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Bausch Health's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Bausch Price To Book vs. EBITDA
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Bausch Health |
| = | 2.2 B |
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Bausch Health |
| = | 18.74 X |
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
Bausch Price To Book Comparison
Bausch Health is currently under evaluation in price to book category among its peers.
Bausch Health Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Bausch Health, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Bausch Health will eventually generate negative long term returns. The profitability progress is the general direction of Bausch Health's change in net profit over the period of time. It can combine multiple indicators of Bausch Health, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -1.9 B | -1.8 B | |
| Operating Income | 963 M | 1 B | |
| Income Before Tax | -390 M | -409.5 M | |
| Total Other Income Expense Net | -1.4 B | -1.3 B | |
| Net Loss | -611 M | -580.5 M | |
| Income Tax Expense | 221 M | 232.1 M | |
| Net Loss | -611 M | -641.5 M | |
| Net Loss | -202.5 M | -212.6 M | |
| Interest Income | 26 M | 24.7 M | |
| Net Interest Income | -1.3 B | -1.4 B | |
| Change To Netincome | -1.4 B | -1.4 B | |
| Net Loss | (1.62) | (1.54) | |
| Income Quality | (1.69) | (1.60) | |
| Net Income Per E B T | 1.52 | 1.59 |
Bausch Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Bausch Health. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Bausch Health position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Bausch Health's important profitability drivers and their relationship over time.
Use Bausch Health in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bausch Health position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bausch Health will appreciate offsetting losses from the drop in the long position's value.Bausch Health Pair Trading
Bausch Health Companies Pair Trading Analysis
The ability to find closely correlated positions to Bausch Health could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bausch Health when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bausch Health - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bausch Health Companies to buy it.
The correlation of Bausch Health is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bausch Health moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bausch Health Companies moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bausch Health can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Bausch Health position
In addition to having Bausch Health in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Pharmaceutical Products Thematic Idea Now
Pharmaceutical Products
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Pharmaceutical Products theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Pharmaceutical Products Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Trending Equities. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
To fully project Bausch Health's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Bausch Health Companies at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Bausch Health's income statement, its balance sheet, and the statement of cash flows.